510(k) Report

510(k) · Cleared

Recalled · Class II · 2024

Vantage Titan with Helios Gradient Model MRT-1504/US

K122613510(k) TraditionalCleared Dec 13, 2012108-day reviewClass II21 CFR 892.1000Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Toshiba America Medical Systems, In.C · LNH System, Nuclear Magnetic Resonance Imaging

Cleared on Dec 13, 2012 as substantially equivalent to K120638 (Toshibamedical Systems Corporation, 2012) and 1 other predicate after a 108-day review. Its family tree reaches back 8 generations to 2000. It has been recalled 3 times.

Decided
Dec 13, 2012
Review
108 days
Class
Class II
Product code
LNH
Recalls
3
Predicates
2

Its longest line of descent runs back 8 generations to K002531 (2000). No later device cites it as a predicate yet.

  1. Root · 8 generations backK002531 Excelart with Pianissimo, Model MRT-1501/P3Toshiba America Mri, Inc. · 2000 · Recalled
  2. 7 generations backK023511 Excelart with Pianissimo XG/AG Spin Edition, Model MRT-1501/P3, P2Toshiba America Medical Systems, In.C · 2002 · Recalled
  3. 6 generations backK032490 Toshiba Excelart Vantage XGV/Agv Mri Diagnostic System, Models…Toshiba America Medical Systems, In.C · 2003 · Recalled
  4. 5 generations backK060003 Excelart Vantage ZGVToshibamedical Systems Corporation · 2006 · Recalled
  5. 4 generations backK063361 Excelart Vantage Atlas, Model MRT-1503Toshiba America Medical Systems, In.C · 2006 · Recalled
  6. 3 generations backK080038 Vantage Titan, Model MRT-1504/S3Toshiba America Medical Systems, In.C · 2008 · Recalled
  7. 2 generations backK112003 Vantage Titan HSRToshibamedical Systems Corporation · 2011
  8. 1 generation backK120638 Vantage TitanToshibamedical Systems Corporation · 2012 · Recalled
  9. This deviceK122613 Vantage Titan with Helios Gradient Model MRT-1504/USToshiba America Medical Systems, In.C · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K002531Excelart with Pianissimo, Model MRT-1501/P3Toshiba America Mri, Inc.20004
−7K023511Excelart with Pianissimo XG/AG Spin Edition, Model MRT-1501/P3, P2Toshiba America Medical Systems, In.C20022
−6K032490Toshiba Excelart Vantage XGV/Agv Mri Diagnostic System, Models MRT-1503/P3 and…Toshiba America Medical Systems, In.C20033
−5K060003Excelart Vantage ZGVToshibamedical Systems Corporation20061
−4K063361Excelart Vantage Atlas, Model MRT-1503Toshiba America Medical Systems, In.C20061
−3K080038Vantage Titan, Model MRT-1504/S3Toshiba America Medical Systems, In.C20082
−2K112003Vantage Titan HSRToshibamedical Systems Corporation2011—
−1K120638Vantage TitanToshibamedical Systems Corporation20122
0 (this device)K122613Vantage Titan with Helios Gradient Model MRT-1504/USToshiba America Medical Systems, In.C2012—
FIG. 1 — Lineage of K122613, 2000–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LNH device

  1. #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120638Vantage Titan
Summary page 2
…otification 51 0(k) Vantage Titan, v2.1, MRT-I 504/US 8. PREDICATE DEVICE(S): a. K120638: Vantage Titan, MRT-1504/U4 b. K1 12003: Vantage Titan HSR,I MRT-1 504/AS 9. REASON FOR SUMBISSION: Modificat…
Toshibamedical Systems Corporation20122
*K112003Vantage Titan HSR
Summary page 2
…Vantage Titan, v2.1, MRT-I 504/US 8. PREDICATE DEVICE(S): a. K120638: Vantage Titan, MRT-1504/U4 b. K1 12003: Vantage Titan HSR,I MRT-1 504/AS 9. REASON FOR SUMBISSION: Modification of adceared device 10. Submission Type Tra…
Toshibamedical Systems Corporation2011—

Also cleared against K120638: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 10, 2024Class IIZ-2041-2024Device DesignThe terminal block used to secure the power supply cable for the gradient coil of the MRI system was not secured as designed, which could cause cable disconnection, which could lead to arcing, followed by melting of the cable, ignition…
Jan 29, 2024Class IIZ-1250-2024Component change controlFor some MRI systems, it has been found that some of the maximum Spatial Field Gradient (SFG) values displayed in "System Information" of the operation window and some of the maximum SFG values described in the safety manual are lower…
May 21, 2021Class IIZ-2044-2021Under Investigation by firmThe MRI system contains a component that does not meet the appropriate flame retardancy-rating which could result in smoke or fire.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 1.2 years on median.
  • 7 of the 8 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K120638.

How does its category compare?

All LNH devices

LNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · LNH

26in 2025

2007: 122008: 192009: 172010: 122011: 162012: 222013: 192014: 172015: 192016: 202017: 182018: 292019: 262020: 322021: 272022: 302023: 302024: 262025: 262026 (partial year): 24
2007high 32 (2020) · low 12 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNH

122in 2025

2007: 35 days median2008: 53 days median2009: 70 days median2010: 94 days median2011: 81 days median2012: 89 days median2013: 108 days median2014: 108 days median2015: 140 days median2016: 108 days median2017: 98 days median2018: 128 days median2019: 62 days median2020: 121 days median2021: 87 days median2022: 74 days median2023: 124 days median2024: 104 days median2025: 122 days median2026 (partial year): 126 days median
2007high 140 (2015) · low 35 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LNH

8in 2025

2007: 252008: 122009: 72010: 172011: 112012: 52013: 22014: 132015: 12, 2 Class I2016: 12018: 712019: 52020: 42021: 412022: 132023: 10, 1 Class I2024: 42025: 8, 5 Class I2026 (partial year): 43
2007high 71 (2018) · low 0 (2017)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · LNH

1,263in 2025

2007: 1142008: 1672009: 1942010: 1652011: 1822012: 1702013: 1072014: 1192015: 1132016: 1352017: 1212018: 1582019: 1582020: 982021: 842022: 1382023: 1592024: 2812025: 1,263
2007high 1,263 (2025) · low 84 (2021)2025

MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007123525114
2008195312167
200917707194
2010129417165
2011168111182
201222895170
2013191082107
20141710813119
20151914012 (2)113
2016201081135
201718980121
20182912871158
201926625158
202032121498
202127874184
2022307413138
20233012410 (1)159
2024261044281
2025261228 (5)1,263
20262412643—

What is it indicated for?

The MRI system is indicated for use as a diagnostic imaging modality that produces cross-sectional transaxial, coronal, sagittal, and oblique images that display anatomic structures of the head or body. In addition, this system supports non-contrast MRA. MRI (magnetic resonance imaging) images correspond to the spatial distribution of protons (hydrogen nuclei) that exhibit nuclear magnetic resonance (NMR). The NMR properties of body tissues and fluids…

Read the full statement (116 words)

The MRI system is indicated for use as a diagnostic imaging modality that produces cross-sectional transaxial, coronal, sagittal, and oblique images that display anatomic structures of the head or body. In addition, this system supports non-contrast MRA. MRI (magnetic resonance imaging) images correspond to the spatial distribution of protons (hydrogen nuclei) that exhibit nuclear magnetic resonance (NMR). The NMR properties of body tissues and fluids are:

- Proton density (PD) (also called hydrogen density),

- Spin-lattice relaxation time (Ti1),

- Spin-spih relaxation time (T2),

- Flow dynamics,

- Chemical shift.

Contrast agent use is restricted to the approved drug indications. When interpreted by a trained physician, these images yield information that can be useful in diagnosis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K122613: Vantage Titan with Helios Gradient Model MRT-1504/US.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K122613

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026